This update includes 20 studies with 2570 patients. Pooled results from studies using a non-Rotta preparation or adequate allocation concealment failed to show benefit in pain and WOMAC function while those studies evaluating the Rotta preparation show that glucosamine was superior to placebo in the treatment of pain and functional impairment resulting from symptomatic OA. WOMAC outcomes of pain, stiffness and function did not show a superiority of glucosamine over placebo for both Rotta and non-Rotta preparations of glucosamine. Glucosamine was as safe as placebo.

Glucosamine

Health conditions analyzed in this study

Osteoarthritis

1 supplement Slightly Positive Glucosamine

Functions related to this study

Joint support

1 supplement Slightly Positive Glucosamine

---

Body systems related to this study

Skeletal System

1 supplement Glucosamine